ID: ALA3576937

Max Phase: Preclinical

Molecular Formula: C15H17N3O3

Molecular Weight: 287.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N[C@@H](CCC(=O)Nc1ccccc1-n1cccc1)C(=O)O

Standard InChI:  InChI=1S/C15H17N3O3/c16-11(15(20)21)7-8-14(19)17-12-5-1-2-6-13(12)18-9-3-4-10-18/h1-6,9-11H,7-8,16H2,(H,17,19)(H,20,21)/t11-/m0/s1

Standard InChI Key:  CZKXIWMWGHXNES-NSHDSACASA-N

Associated Targets(Human)

Neutral amino acid transporter B(0) 65 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 287.32Molecular Weight (Monoisotopic): 287.1270AlogP: 1.61#Rotatable Bonds: 6
Polar Surface Area: 97.35Molecular Species: ZWITTERIONHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.09CX Basic pKa: 9.31CX LogP: -0.80CX LogD: -0.80
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.75Np Likeness Score: -0.82

References

1. Schulte ML, Dawson ES, Saleh SA, Cuthbertson ML, Manning HC..  (2015)  2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency.,  25  (1): [PMID:25435145] [10.1016/j.bmcl.2014.10.098]

Source